Back
Trevi Therapeutics 10K Form
Buy
75
TRVI
Trevi Therapeutics
Last Price:
$6.41
Seasonality Move:
16.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRVI News And Ratings
See the #1 stock for the next 7 days that we like better than TRVI
TRVI Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-9.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.06 |
| Price / Book: | 6.28 |
Profitability
| EPS (TTM): | -0.47000 |
|---|---|
| Net Income (TTM): | $-47.9M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Trevi Therapeutics Earnings Forecast
Key Trevi Therapeutics Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 5 years.
Trevi Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TRVI |
| CUSIP: | 89532M |
| Website: | trevitherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRVI Technical Analysis vs Fundamental Analysis
Buy
75
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $6.47. The Score for TRVI is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.